Added to YB: 2024-09-02
Pitch date: 2024-08-30
HIMS [neutral]
Hims & Hers Health, Inc.
+35.43%
current return
Author Info
MBR's Substack is an undergraduate at Seoul Nat'l University sharing investment writeups. Sign up for the newsletter.
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$14.65
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
growth
Hims & Hers Health, Inc. - $HIMS
HIMS (wait for dip): Strong Q2 with 43.4% YoY subscriber growth to 1.86M, 50%+ revenue growth. Marketing costs down, margins stable. Raised guidance. FCF ~$50M. Personalized solutions up 164% YoY. GLP-1 launch adds $10M revenue. Valuation attractive post-GLP-1 concerns. Buy in stages at $12-13 or 10-15% below current price.
Read full article (3 min)